Cargando…

Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2

OBJECTIVE: Secretory leukocyte peptidase inhibitors (SLPI), elafin, squamous cell carcinoma antigen 1 and 2 (SCCA1 and SCCA2) are specific endogenous serine protease inhibitors expressed by epithelial cells that prevent tissue damage from excessive proteolytic enzyme activity due to inflammation. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Lei, Swanson, Bryan, An, Jonathan, Hacker, Beth M., Silverman, Gary A., Dale, Beverly A., Chung, Whasun O.
Formato:	Texto
Lenguaje:	English
Publicado:	CoAction Publishing 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084571/ https://www.ncbi.nlm.nih.gov/pubmed/21523231 http://dx.doi.org/10.3402/jom.v2i0.5070

Ejemplares similares

Adoptive TIL in HPV-negative oral scca
por: Leidner, Rom, et al.
Publicado: (2015)

Salivary Scca1, Scca2 and Trop2 in Oral Cancer Patients—A Cross-Sectional Pilot Study
por: Karmelić, Ivana, et al.
Publicado: (2022)

Metabolomics and lipid profile analysis of Coccomyxa melkonianii SCCA 048
por: Fais, Giacomo, et al.
Publicado: (2021)

SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation
por: Wang, Songyan, et al.
Publicado: (2022)

Elevated Expression of Squamous Cell Carcinoma Antigen (SCCA) Is Associated with Human Breast Carcinoma
por: Catanzaro, Joseph M., et al.
Publicado: (2011)

Secretory Leukocyte Protease Inhibitor (SLPI) Is, like Its Homologue Trappin-2 (Pre-Elafin), a Transglutaminase Substrate
por: Baranger, Kévin, et al.
Publicado: (2011)

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC
por: Trerotoli, Paolo, et al.
Publicado: (2009)

Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer
por: Qu, Tao, et al.
Publicado: (2019)

Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma
por: Zheng, Xin, et al.
Publicado: (2014)

Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty
por: Du, Lei, et al.
Publicado: (2017)

Exploring Brain Structural and Functional Biomarkers in Schizophrenia via Brain-Network-Constrained Multi-View SCCA
por: Song, Peilun, et al.
Publicado: (2022)

Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases
por: Izuhara, Kenji, et al.
Publicado: (2018)

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
por: Beale, Gary, et al.
Publicado: (2008)

Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
por: Fassan, Matteo, et al.
Publicado: (2016)

Associations between the expression of SCCA, MTA1, P16, Ki-67 and the infection of high-risk HPV in cervical lesions
por: Han, Cuina, et al.
Publicado: (2020)

15-PGJ(2), but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells
por: Nikitakis, N G, et al.
Publicado: (2002)

PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level
por: Cao, Lianjing, et al.
Publicado: (2017)

The value of squamous cell carcinoma antigen (SCCa) to determine the lymph nodal metastasis in cervical cancer: A meta-analysis and literature review
por: Zhou, Ziqi, et al.
Publicado: (2017)

Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer
por: Ran, Chao, et al.
Publicado: (2021)

SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production
por: Chen, Liyun, et al.
Publicado: (2023)

The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.
por: Westin, U, et al.
Publicado: (2002)

Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.
por: Nyström, M, et al.
Publicado: (1999)

Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome
por: Dickey, Brittney L., et al.
Publicado: (2021)

A sandwich SERS immunoassay platform based on a single-layer Au–Ag nanobox array substrate for simultaneous detection of SCCA and survivin in serum of patients with cervical lesions
por: Liu, Yifan, et al.
Publicado: (2021)

Challenges to development of cervical and breast cancer program development in post conflict Liberia: Presentation prepared for African First Ladies' Conference, 10th SCCA Conference, Addis Ababa, Ethiopia 2016
por: Beddoe, Ann Marie
Publicado: (2017)

The Serine Protease Inhibitor Elafin Maintains Normal Growth Control by Opposing the Mitogenic Effects of Neutrophil Elastase
por: Caruso, Joseph A., et al.
Publicado: (2014)

Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
por: Wex, Thomas, et al.
Publicado: (2011)

Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells
por: Sayers, Kevin T., et al.
Publicado: (2014)

Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2022)

How SLPI soothes
por: Van Epps, Heather L.
Publicado: (2005)

Periopathogens in atherosclerotic plaques of patients with both cardiovascular disease and chronic periodontitis
por: Atarbashi-Moghadam, Fazele, et al.
Publicado: (2018)

Identification of Periopathogens in Atheromatous Plaques Obtained from Carotid and Coronary Arteries
por: Pavlic, Verica, et al.
Publicado: (2021)

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers
por: Kozin, Sergey V., et al.
Publicado: (2017)

Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2
por: Xie, Ying, et al.
Publicado: (2022)

Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer
por: Hunt, Kelly K, et al.
Publicado: (2013)

Periopathogenic bacteria in dental plaque of Congolese patients with periodontitis: A pilot study
por: Kalala-Kazadi, Em, et al.
Publicado: (2018)

Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
por: Lange, Anna, et al.
Publicado: (2019)

Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury
por: Kongpol, Kantapich, et al.
Publicado: (2019)

Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells
por: Wei, Zhijiang, et al.
Publicado: (2023)

Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT
por: Wei, Zhijiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_paasq372cj1685o2dg1g4etjfa